Elyse A. Beebe

518 total citations
12 papers, 404 citations indexed

About

Elyse A. Beebe is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Elyse A. Beebe has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Elyse A. Beebe's work include Tuberculosis Research and Epidemiology (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (5 papers). Elyse A. Beebe is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (5 papers). Elyse A. Beebe collaborates with scholars based in United States, Netherlands and Denmark. Elyse A. Beebe's co-authors include Steven G. Reed, Mark T. Orr, Rhea N. Coler, Christopher B. Fox, Po‐Wei Huang, Valerie A. Reese, Thomas E. Hudson, Susan L. Baldwin, James Moon and Brendan K. Podell and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Elyse A. Beebe

12 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elyse A. Beebe United States	11	250	206	128	127	30	12	404
Marco Tortoli Italy	6	535 2.1×	77 0.4×	183 1.4×	176 1.4×	34 1.1×	7	674
Fengmin Zhou United States	9	192 0.8×	92 0.4×	118 0.9×	85 0.7×	19 0.6×	15	354
Giuseppe Lofano Italy	9	256 1.0×	127 0.6×	86 0.7×	151 1.2×	74 2.5×	13	412
Jacqueline de Vries‐Idema Netherlands	13	171 0.7×	105 0.5×	196 1.5×	89 0.7×	17 0.6×	22	355
Sabine Nakowitsch Austria	11	100 0.4×	75 0.4×	153 1.2×	97 0.8×	29 1.0×	14	328
N Venkataprasad United Kingdom	8	225 0.9×	277 1.3×	228 1.8×	97 0.8×	14 0.5×	15	426
Wilson Caparrós‐Wanderley United Kingdom	11	190 0.8×	79 0.4×	197 1.5×	165 1.3×	32 1.1×	17	399
Kaila M. Bennett United States	7	166 0.7×	77 0.4×	65 0.5×	114 0.9×	11 0.4×	7	346
Umesh Shaligram India	10	146 0.6×	188 0.9×	89 0.7×	135 1.1×	17 0.6×	30	429
Izaíra Tincani Brandão Brazil	12	173 0.7×	180 0.9×	144 1.1×	135 1.1×	4 0.1×	20	398

Countries citing papers authored by Elyse A. Beebe

Since Specialization

Citations

This map shows the geographic impact of Elyse A. Beebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyse A. Beebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyse A. Beebe more than expected).

Fields of papers citing papers by Elyse A. Beebe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyse A. Beebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyse A. Beebe. The network helps show where Elyse A. Beebe may publish in the future.

Co-authorship network of co-authors of Elyse A. Beebe

This figure shows the co-authorship network connecting the top 25 collaborators of Elyse A. Beebe. A scholar is included among the top collaborators of Elyse A. Beebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyse A. Beebe. Elyse A. Beebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Baldwin, Susan L., Valerie A. Reese, Sasha E. Larsen, et al.. (2021). Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PLoS ONE. 16(3). e0247990–e0247990. 27 indexed citations

Kramer, Ryan M., Michelle Archer, Mark T. Orr, et al.. (2018). Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. International Journal of Nanomedicine. Volume 13. 3689–3711. 30 indexed citations

Fox, Christopher B., Mark T. Orr, Neal Van Hoeven, et al.. (2016). Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach. Journal of Controlled Release. 244(Pt A). 98–107. 44 indexed citations

Beebe, Elyse A. & Mark T. Orr. (2016). Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture Supernatants. Methods in molecular biology. 1494. 313–320. 6 indexed citations

Baldwin, Susan L., Will Roeffen, Susheel Kumar Singh, et al.. (2016). Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen. Vaccine. 34(19). 2207–2215. 34 indexed citations

Orr, Mark T., Hillarie Plessner Windish, Elyse A. Beebe, et al.. (2015). Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4⁺T-Cell Responses for Vaccine Control of Tuberculosis. The Journal of Infectious Diseases. 212(3). 495–504. 25 indexed citations

Orr, Mark T., Elyse A. Beebe, Thomas E. Hudson, et al.. (2015). Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Vaccine. 33(48). 6570–6578. 39 indexed citations

Baldwin, Susan L., Valerie A. Reese, Po‐Wei Huang, et al.. (2015). Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate. Clinical and Vaccine Immunology. 23(2). 137–147. 44 indexed citations

Coler, Rhea N., Thomas E. Hudson, Sean M. Hughes, et al.. (2015). Vaccination Produces CD4 T Cells with a Novel CD154–CD40-Dependent Cytolytic Mechanism. The Journal of Immunology. 195(7). 3190–3197. 15 indexed citations

10.

Orr, Mark T., Ryan M. Kramer, Quinton M. Dowling, et al.. (2014). Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization. Journal of Controlled Release. 177. 20–26. 41 indexed citations

11.

Orr, Mark T., Elyse A. Beebe, Thomas E. Hudson, et al.. (2014). A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93. PLoS ONE. 9(1). e83884–e83884. 64 indexed citations

12.

Orr, Mark T., Gregory C. Ireton, Elyse A. Beebe, et al.. (2014). Immune Subdominant Antigens as Vaccine Candidates against Mycobacterium tuberculosis. The Journal of Immunology. 193(6). 2911–2918. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact